Jfs Wealth Advisors, LLC Agios Pharmaceuticals, Inc. Transaction History
Jfs Wealth Advisors, LLC
- $1.56 Billion
- Q2 2025
A detailed history of Jfs Wealth Advisors, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Jfs Wealth Advisors, LLC holds 16 shares of AGIO stock, worth $643. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16
Previous 5
220.0%
Holding current value
$643
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding AGIO
# of Institutions
236Shares Held
61.8MCall Options Held
297KPut Options Held
235K-
Farallon Capital Management LLC San Francisco, CA5.77MShares$232 Million0.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.68MShares$229 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$196 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.59MShares$144 Million2.72% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.33MShares$93.6 Million0.65% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.21B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...